Notice of Annual General Meeting/Proxy Form
Released
Released
Announcement PDF
WISR LIMITED
ACN 004 661 205
NOTICE OF ANNUAL GENERAL MEETING
Notice is hereby given that the Annual General Meeting of Shareholders of Wisr Limited (Company)
will be held at the offices of BDO East Coast Partnership, Level 11, 1 Margaret Street, Sydney NSW
2000 on Tuesday 26 November 2019 at 3.00pm (AEDT) (Meeting).
The Explanatory Notes to this Notice provide additional information on the matters to be considered
at the Meeting. The Explanatory Notes and the Proxy Form form part of this notice.
BUSINESS OF THE MEETING
Item 1: Financial Statements and Reports
To receive and consider the Financial Report, the Directors’ Report and the Auditor’s Report of the
Company for the year ended 30 June 2019.
Item 2: Remuneration Report
To consider and, if thought fit, to pass the following as an ordinary resolution of the Company:
“To adopt the Remuneration Report for the year ended 30 June 2019.”
Notes:
(i)
(ii)
In accordance with section 250R of the Corporations Act, the vote on this resolution will
be advisory only and will not bind the Directors or the Company.
A voting exclusion statement applies to this resolution (see Explanatory Notes for details).
Item 3: Re-election of Director
To consider and, if thought fit, to pass the following as an ordinary resolution of the Company:
“That Mr John Nantes, being a Director who is retiring in accordance with Clause 59.1 of the Company’s
Constitution and ASX Listing Rule 14.4, and being eligible, offers himself for re-election, be re-elected
as a Director of the Company.”
Item 4: Grant of Performance Rights to John Nantes
To consider and, if thought fit, pass the following as an ordinary resolution of the Company:
“That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, Shareholders approve the
grant and issue of 10,270,000 Performance Rights to Mr John Nantes or his nominee (and the
Page 1
subsequent issue or transfer of Shares on the vesting of such Performance Rights) under the Plan as
further detailed in the Explanatory Notes to this Notice of Meeting.”
Note: A voting exclusion statement applies to this resolution (see Explanatory Notes for details).
Item 5: Grant of Performance Rights to Craig Swanger
To consider and, if thought fit, pass the following as an ordinary resolution of the Company:
“That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, Shareholders approve the
grant and issue of 6,560,000 Performance Rights to Mr Craig Swanger or his nominee (and the
subsequent issue or transfer of Shares on the vesting of such Performance Rights) under the Plan as
further detailed in the Explanatory Notes to this Notice of Meeting.”
Note: A voting exclusion statement applies to this resolution (see Explanatory Notes for details).
Item 6: Grant of Performance Rights to Chris Whitehead
To consider and, if thought fit, pass the following as an ordinary resolution of the Company:
“That, for the purposes of ASX Listing Rule 10.14 and for all other purposes, Shareholders approve the
grant and issue of 5,700,000 Performance Rights to Mr Chris Whitehead or his nominee (and the
subsequent issue or transfer of Shares on the vesting of such Performance Rights) under the Plan as
further detailed in the Explanatory Notes to this Notice of Meeting.”
Note: A voting exclusion statement applies to this resolution (see Explanatory Notes for details).
Item 7: Additional 10% Placement Capacity
To consider and, if thought fit, to pass the following as a special resolution of the Company:
“That, for the purposes of Listing Rule 7.1A and for all other purposes, to approve the issue of additional
Equity Securities up to 10% of the issued capital of the Company (at the time of issue), calculated in
accordance with the formula prescribed in Listing Rule 7.1A.2 and on the terms and conditions set out
in the Explanatory Notes.”
ENTITLEMENT TO VOTE
_________________________________________________________________________
The Directors have determined that the persons eligible to vote at the Meeting are those who are
registered Shareholders of the Company as at 7.00 p.m. (AEDT) on Sunday 24 November 2019
(Entitlement Time), subject to any applicable voting exclusion.
This means that if you are not the registered holder of a Share in the Company at the Entitlement
Time, you will not be entitled to vote at the Meeting.
ANNUAL REPORT
_________________________________________________________________________
Copies of the Company's 2019 Annual Report may be accessed at our website https://wisr.com.au/ or
from the Company.
Page 2
VOTING OPTIONS AND PROXIES
_________________________________________________________________________
If you do not plan to attend the Meeting in person, you are encouraged to complete and return the
Proxy Form, which accompanies this Notice of Annual General Meeting.
Voting by Proxy
A Shareholder who is entitled to attend and vote at this Meeting is entitled to appoint not more than
two proxies to attend and vote in place of the Shareholder.
If the Shareholder appoints two proxies, the Shareholder may specify the proportion or number of
votes each proxy is entitled to exercise. If no proportion or number of votes is specified, each proxy
may exercise half of the Shareholder’s votes. If the specified proportion or number of votes exceeds
that which the Shareholder is entitled to, each proxy may exercise half of the Shareholder’s votes. Any
fractions of votes brought about by the apportionment of votes to a proxy will be disregarded.
A proxy need not be a Shareholder of the Company. A body corporate appointed as a shareholder’s
proxy may appoint a representative to exercise any of the powers the body may exercise as a proxy
at the Meeting. The representative should bring to the Meeting evidence of his or her appointment,
including any authority under which the appointment is signed, unless it has previously been given to
the Company.
Subject to the specific proxy provisions applying to Item 2 (see the Explanatory Notes below):
-
If a Shareholder has not directed their proxy how to vote, the proxy may vote (or abstain from
voting) as the proxy determines, and
If a Shareholder appoints the Chairman of the Meeting as proxy and does not direct the
Chairman how to vote on an item of business, the Chairman will vote in accordance with his
voting intention as stated in this Notice of Meeting, namely in favour of each of the proposed
resolutions set out in the Notice of Meeting.
Proxy Voting by the Chairman
For Item 2 (Remuneration Report), Items 4, 5, 6 (Grant of Performance Rights to Directors), where the
Chairman is appointed as a Shareholder’s proxy and that shareholder has not specified the way in
which the Chairman is to vote on Items 2, 4, 5, 6, the Shareholder is directing the Chairman to vote in
accordance with the Chairman’s voting intentions for this item of business, even though Items 2, 4, 5,
6 are connected directly or indirectly with the remuneration of Key Management Personnel.
The Chairman intends to vote all undirected proxies in favour of the resolutions in the Notice of
Meeting, including Items 2, 4, 5 and 6.
Proxy Forms
To be effective, the Proxy Form must be completed, signed and lodged (together with the relevant
original power of attorney or a certified copy if the proxy is signed by an attorney) with the Company’s
Share Registry, as an original or by facsimile, no later than 3.00 p.m. (AEDT) on Sunday 24 November
2019 (Proxy Deadline).
Page 3
Proxy forms may be submitted in one of the following ways:
(i)
By mail to Computershare Investor Services Pty Limited using the reply-paid envelope or GPO
Box 242, Melbourne VIC 3001. Please allow sufficient time so that it reaches Computershare
Investor Services Pty Ltd by the Proxy Deadline;
(ii)
By fax to Computershare Investor Services Pty Limited on +1800 783 447 (within Australia) or
+61 3 9473 2555 (outside Australia);
(iii)
Online via the Company’s Share Registry website at www.investorvote.com.au. Please refer to
the Proxy Form for more information; or
(iv)
By hand delivery to Computershare Investor Services Pty Limited at Level 3, 60 Carrington
Street, Sydney NSW 2000.
Proxy Forms and Powers of Attorney must be received by the Proxy Deadline.
CORPORATE REPRESENTATIVES
_________________________________________________________________________
Where a shareholding is registered in the name of a corporation, the corporate Shareholder may
appoint a person to act as its representative to attend the Meeting by providing that person with:
(i)
(ii)
a letter or certificate authorising him or her as the corporation's representative, executed in
accordance with the corporation's constitution; or
a copy of the resolution appointing the representative, certified by a secretary or director of
the corporation.
BY ORDER OF THE BOARD
Vanessa Chidrawi
Company Secretary
21 October 2019
Page 4
Explanatory Notes
ITEM 1 – Financial Statements and Reports
As required by section 317 of the Corporations Act, the Financial Report, Directors' Report and
Auditor’s Report of the Company for the most recent financial year will be presented at the Meeting.
The Financial Report comprises the consolidated financial report of the Company and its controlled
entities.
There is no requirement for a formal resolution on this Item.
The Chairman of the Meeting will allow a reasonable opportunity at the Meeting for Shareholders to
ask questions about or make comments on the management of the Company. Shareholders will also
be given a reasonable opportunity at the Meeting to ask the Company’s auditor, BDO East Coast
Partnership (BDO), questions about the Auditor’s Report, the conduct of its audit of the Company’s
Financial Report for the year ended 30 June 2019, the preparation and content of the Auditor’s Report,
the accounting policies adopted by the Company in its preparation of the financial statements and the
independence of BDO in relation to the conduct of the audit.
Shareholders may submit written questions to the Company in relation to the above matters. Written
questions must be received no later than 5.00 p.m. (AEDT) on Tuesday 19 November 2019. A form to
facilitate the submission of questions is attached to this Notice and it includes instructions for the
return of this form to the Share Registry.
ITEM 2 – Adoption of Remuneration Report
Reasons for Resolution
In accordance with section 300A of the Corporations Act the Company has proposed a Remuneration
Report for the consideration of Shareholders.
As provided by section 250R(3) of the Corporations Act, the resolution on this item of business is
advisory only and does not bind the Board or the Company.
The objective of the Company's executive reward framework is to ensure reward for performance is
competitive and appropriate for the results delivered. In order to align remuneration with
shareholders’ interests, the framework:
-
has economic profit as a core component;
focuses on sustained growth in shareholder wealth as well as focusing the executive on key
non-financial drivers of value; and
attracts and retains high calibre executives who receive a base salary which is based on factors
such as length of service and experience, superannuation, and performance incentives.
Directors’ Recommendation
Noting that each Director of the Company has a personal interest in their own remuneration the
subject of this resolution, the Board does not consider it appropriate to make a recommendation to
Shareholders in relation to voting on this resolution.
Page 5
Voting Exclusion Statement
As required by the Corporations Act, the Company will disregard any votes cast on Item 2 by any
member of the Company’s Key Management Personnel (Key Management Personnel or KMP) or a
Closely Related Party of any such member unless:
(i)
(ii)
that person votes as a proxy appointed in writing (on behalf of a person who is entitled to
vote on this Item 2) that specifies how the person is to vote on Item 2; or
the person is the Chair of the Meeting and votes as a proxy appointed in writing (on behalf of
a person who is entitled to vote on this Item 2) that authorises the Chair to vote on the
resolution even though that resolution is connected with the remuneration of a member of
the Company’s KMP.
What this means for shareholders: If you intend to appoint a member of the KMP (such as one of the
Directors) as your proxy, please ensure that you direct them how to vote on the proposed resolution
in Item 2. If you intend to appoint the Chairman of the Meeting as your proxy, you can direct him how
to vote by marking the boxes for Item 2 (for example, if you wish to vote for, against or abstain from
voting), or you can choose not to mark any of the boxes for Item 2 and give the Chairman your express
authority to vote your undirected proxy (in which case the Chairman will vote in favour of this item of
business).
ITEM 3 - Re-election of Director
In accordance with the Company’s Constitution and ASX Listing Rule 14.5 an election of Directors must
be held at each annual general meeting. Clause 59 of the Constitution states that at each AGM, every
Director who has been in office the longer of a period of three years as at the commencement of that
meeting or a period since the conclusion of the earliest of the three annual general meetings
immediately preceding that meeting must retire.
Mr John Nantes was last elected by Shareholders on 17 November 2016 and pursuant to Clause 59.1
of the Constitution and ASX Listing Rule 14.4, resigns by rotation and is eligible for re-election at this
meeting. Details regarding Mr Nantes are set out below.
Mr Nantes was appointed as a non-executive director of the Company on 7 June 2016.
Mr Nantes has over 23 years’ experience in financial services. Prior to being appointed the Chief
Executive Officer of Adcock Private Equity, Mr Nantes was Group Head of Financial Services at Crowe
Horwath, which held over $10 billion in funds under management and was Australia's largest SMSF
provider with over 10,000 funds. Mr Nantes has also been the CEO of Prescott Securities, a
Stockbroking and Financial Planning business managing over $2b in FUM, as well as the CEO of WHK
Eastern Victoria, an accounting and specialist tax business. Mr Nantes has held various Chief Executive
roles in financial services and Senior Executive roles in St George Bank and Colonial State Bank across
retail, private banking and wealth management. Mr Nantes is also currently an Executive Chairman
and Responsible Manager for Cashwerkz Limited (ASX:CWZ), a financial services company and NonExecutive Director of Thinkxtra, a non-listed IOT public company. Mr Nantes has bachelor’s degrees in
law, Commerce, and Arts and holds a Diploma in Financial Planning.
Having had regard to the ASX Principles, Mr Nantes is regarded as a non-independent director given
his appointment as Executive Chairman of the Company commenced on 19 August 2016.
Page 6
Directors’ Recommendation
The Directors (other than Mr Nantes) unanimously support the re-election of Mr Nantes and
recommend that Shareholders vote in favour of this resolution.
ITEMS 4, 5 and 6 - Grant of Performance Rights to Directors
ASX Listing Rule 10.14 provides that the Company must not permit any Director to acquire securities
under an employee incentive scheme without the approval of Shareholders.
Accordingly, Items 4, 5 and 6 seek the approval of Shareholders pursuant to ASX Listing Rule 10.14 to
grant Performance Rights (Rights) to Directors of the Company, in accordance with the terms of the
Company’s Performance Rights Plan (Plan), and to the issue or transfer of Shares on the vesting of
the Rights, as outlined below.
As the Rights are to be issued under the Plan, the rules of the Plan govern the Rights to be issued to
the Directors.
To ensure alignment of the interests of Shareholders and Directors, non-executive director
remuneration is designed to attract and retain directors of the highest calibre, whilst incurring a cost
which is acceptable to shareholders. The Constitution and the ASX Listing Rules specify that the
aggregate remuneration of non-executive directors shall be determined from time to time by a general
meeting. An amount not exceeding the amount determined is then divided between the directors as
agreed. The latest determination was adopted by a special resolution passed at the Annual General
Meeting held on 24 November 2006 when shareholders approved an aggregate remuneration of up
to a maximum of $500,000 per year.
The aggregate remuneration is reviewed annually. The remuneration for non-executive directors is
comprised of cash, superannuation contributions and performance rights.
Details of Rights grant to Directors
It is proposed that the Directors be issued the following Rights:
Director
Position
Number of Rights
Mr John Nantes
Executive Chairman
10,270,000
Mr Craig Swanger
Non-Executive Director
6,560,000
Mr Chris Whitehead
Non-Executive Director
5,700,000
In determining the number of new Rights to be issued to Directors, the Board considered the:
(i)
Company’s remuneration strategy;
(ii)
Company’s situation;
(iii)
role and contribution of each Director to the achievement of the Company’s objectives; and
(iv)
current market practice for remuneration of directors in positions of similar responsibility and
within peer groups.
Page 7
These Rights will vest in tranches if, the volume-weighted average price of the Company’s shares
traded on ASX over any 20-day period (VWAP20) exceeds the prices specified in the table below at
any time between 1 September 2019 and 30 June 2022 (Testing Period), subject to the director
remaining on the Company’s Board.
VWAP
14.5 cents
16.73 cents
19.24 cents
38 cents
1,920,000
1,920,000
1,060,000
2,390,000
1,330,000
1,330,000
2,880,000
1,600,000
1,600,000
3,080,000
1,710,000
1,710,000
No. of Performance Rights
that will vest:
Mr Nantes
Mr Swanger
Mr Whitehead
Upon vesting of the relevant tranche or tranches of Rights, the equivalent number of Shares will be
automatically issued to the Directors, subject to the Plan Rules.
Example vesting scenarios
Scenario 1: If at any time during the Testing Period, the VWAP20 exceeds 14.5 cents, 1,920,000 Rights
will vest for each of Mr Nantes and Mr Swanger and they will automatically each be issued 1,920,000
Shares subject to the Plan Rules. For Mr Whitehead, 1,060,000 Rights will vest, and he will
automatically be issued the equivalent number of Shares subject to the Plan Rules.
Scenario 2: If at any time during the Testing Period, the VWAP20 exceeds 16.73 cents, an additional
2,390,000 Rights will vest for Mr Nantes and he will automatically be issued 2,390,000 Shares subject
to the Plan Rules. For the Non-Executive Directors, 1,330,000 Rights will vest for each of Mr Whitehead
and Mr Swanger. This is in addition to the Rights issued under Scenario 1.
Scenario 3: If at any time during the Testing Period, the VWAP20 exceeds 19.24 cents, 2,880,000 Rights
will vest for Mr Nantes and he will automatically be issued 2,880,000 Shares subject to the Plan Rules.
For the Non-Executive Directors, 1,600,000 Rights will vest for each of Mr Whitehead and Mr Swanger.
This is in addition to the Rights issued under Scenarios 1 and 2.
Scenario 4: If at any time during the Testing Period, the VWAP20 exceeds 38 cents, 3,080,000 Rights
will vest for Mr Nantes and he will automatically be issued with 3,080,000 Shares subject to the Plan
Rules. For the Non-Executive Directors, 1,710,000 Rights will vest for each of Mr Whitehead and Mr
Swanger. This is in addition to the Rights issued under Scenarios 1, 2 and 3.
Total Remuneration
Each Director has entered into a Director Service Agreement with the Company, which outlines his
remuneration. Mr Nantes as Executive Chairman receives $100,000.00 per annum (plus
superannuation) and the Rights outlined above if approved by Shareholders.
Non-Executive Directors, Mr Whitehead and Mr Swanger, each receive $60,000 per annum (plus
superannuation) and the Rights outlined above if approved by Shareholders.
The Performance Rights Plan
The Plan only contemplates the grant of Rights over Shares. There is no ability for the Company to
Page 8
provide any cash equivalent on vesting.
Subject to the terms of the Plan, all Rights which have not vested will automatically lapse and be
forfeited without consideration upon cessation of a director’s role.
The terms of the Plan were last approved by Shareholders at the AGM held on 27 November 2018.
Shareholder approval
Listing Rule 10.11 provides a general restriction against issuing equity securities to a related party of a
listed entity without Shareholder approval, unless an exception applies. Exception 4 of Listing Rule
10.12 permits the issue of securities to a related party of a listed entity under an employee incentive
scheme if the issue has been approved by shareholders pursuant to the requirements of Listing Rule
10.14.
Under Items 4, 5 and 6, the Company seeks approval from Shareholders for the issue of Rights to Mr
Nantes, Mr Whitehead and Mr Swanger, being Directors who are related parties of the Company.
Approval is sought in relation to the grant of the Rights to these Directors under the Plan in respect of
the period commencing on and from the date of this Meeting, with the Rights to be granted no later
than 12 months after the date of this Meeting.
Information required by ASX Listing Rule 10.15
ASX Listing Rule 10.15 requires the following information to be disclosed in relation to the Rights
proposed to be granted under the Plan:
(i)
Number and price of securities
The maximum number of Rights that may be acquired by each Director is as follows:
Director
Maximum Number of Rights
Mr John Nantes
10,270,000
Mr Craig Swanger
6,560,000
Mr Chris Whitehead
5,700,000
No consideration is payable by the Directors at the time of the grant of the Rights or upon the issue of
Shares to which they may become entitled on the vesting of some or all the Rights.
(ii) Persons who received securities under the Plan since last approval
54,016,371 Rights were granted to various employees since the last AGM, following shareholder
approval, at a nil acquisition price. In addition to the above grant, 22,896,172 Rights have lapsed
since the last AGM.
Page 9
Total Rights to Directors currently on issue are:
Director
Number of Rights
Mr J Nantes
4,000,000
Mr C Swanger
333,334
Mr C Whitehead
1,500,000
(iii) Persons who are entitled to participate in the Plan
Participation in the Plan and the number of Rights offered to each individual participant is determined
by the Board. Those eligible to participate in the Plan include full-time, part-time or casual employees
or contractors of the Company (including executive Directors, and non-executive Directors of the
Company). The following Directors are current participants in the Plan:
-
John Nantes;
-
Craig Swanger; and
-
Christopher Whitehead.
(iv) Terms of any related loan
There is no loan provided in relation to the acquisition of Rights by any of the Directors.
(v) Issue date of Rights
The Rights will be granted to the Directors no earlier than immediately following this Meeting and no
later than 12 months after the date of the Meeting, on the conditions described in this Explanatory
Note.
Chapter 2E of the Corporations Act
Chapter 2E of the Corporations Act regulates the provision of financial benefits to related parties by a
public company. The issue of Rights to a Director under Items 4, 5 and 6 constitutes the provision of a
financial benefit to related parties.
It is the Board’s view that the proposed issue of Rights pursuant to the resolutions in Items 4, 5 and 6
falls within the exception under section 211 of the Corporations Act (reasonable remuneration) given
the circumstances of the Company and the position held by the director.
In particular, the Board considers that the proposed issue of Rights to the directors is reasonable
remuneration given the circumstances of the Company.
Accordingly, the Board has determined not to seek Shareholder approval under section 208 of the
Corporations Act for the issue of Performance Rights to Messrs Nantes, Swanger and Whitehead.
Page 10
Voting exclusion
The Company will disregard any votes cast in favour of the proposed Items 4, 5, and 6 by or on behalf
of all Directors (as all Directors of the Company are eligible to participate in the Plan) or any associates
of those persons. However, the Company need not disregard a vote if:
a)
it is cast by a person as proxy for a person who is entitled to vote, in accordance with the
directions on the proxy form; or
b)
it is cast by the Chairman as proxy for a person who is entitled to vote, in accordance with a
direction on the proxy form to vote as the proxy does.
In addition, no KMP of the Company or a Closely Related Party of such a KMP may vote as a proxy on
the proposed Items 4, 5 and 6 unless:
a)
the person votes as a proxy appointed by writing that specifies how the person is to vote on the
proposed Items 4, 5 and 6 ; or
b)
the person is the Chairman and votes as a proxy appointed by writing that authorises the
Chairman to vote on the proposed Items 4, 5 and 6 even though the resolution is connected
directly or indirectly with the remuneration of KMP of the Company.
Director’s Recommendation
Item 4: The directors (other than Mr Nantes) unanimously recommend that Shareholders vote in
favour of this resolution.
Item 5: The directors (other than Mr Swanger) unanimously recommend that Shareholders vote in
favour of this resolution.
Item 6: The directors (other than Mr Whitehead) unanimously recommend that Shareholders vote in
favour of this resolution.
ITEM 7 – Additional 10% Placement Capacity
General
ASX Listing Rule 7.1A provides that an Eligible Entity may seek Shareholder approval at its AGM to
allow it to issue Equity Securities up to 10% of its issued capital (10% Placement Capacity). If
Shareholders approve the resolution in Item 7, the number of Equity Securities the Company may issue
under the 10% Placement Capacity will be determined in accordance with the formula prescribed in
ASX Listing Rule 7.1A.2 (as set out below).
The effect of the resolution in Item 7 will be to allow the Directors to issue Equity Securities up to 10%
of the Company’s fully paid ordinary securities on issue under the 10% Placement Capacity during the
period up to 12 months after the Meeting, without Shareholder approval and without using the
Company’s 15% annual placement capacity granted under Listing Rule 7.1.
The resolution in Item 7 is a special resolution. Accordingly, at least 75% of votes cast by Shareholders
present and eligible to vote at the Meeting must be in favour of this resolution for it to be passed.
Page 11
10% Placement Capacity
An eligible entity under ASX Listing Rule 7.1A is one which (at the date of the relevant annual general
meeting) has a market capitalisation of $300 million or less and is not included in the S&P / ASX 300
Index. The Company is an eligible entity for the purposes of ASX Listing Rule 7.1A.
The Company hereby seeks shareholder approval by way of special resolution to have the ability to
issue equity securities under the 10% Placement Capacity.
The Equity Securities must be in the same class as an existing class of quoted Equity Securities. The
Company currently has three classes of Equity Securities on issue, being quoted ordinary shares,
unquoted options and unquoted performance rights.
The exact number of equity securities that may be issued pursuant to the 10% Placement Capacity will
be determined in accordance with the formula prescribed in ASX Listing Rule 7.1A.2 which provides
that eligible entities which have obtained shareholder approval at an annual general meeting may
issue or agree to issue, during the 12-month period after the date of the annual general meeting, a
number of equity securities calculated as follows:
(A x D) – E
Where:
A
is the number of Shares on issue 12 months before the date of issue or the date of agreement
to issue:
(a)
plus the number of Shares issued in the previous 12 months under an exception in ASX
Listing Rule 7.2;
(b)
plus the number of partly paid Shares that became fully paid in the previous 12
months;
(c)
plus the number of Shares issued in the previous 12 months with approval of
Shareholders under Listing Rules 7.1 and 7.4. This does not include an issue of Shares
under the Company’s 15% placement capacity without Shareholder approval; and
(d)
less the number of Shares cancelled in the previous 12 months.
Note that A has the same meaning in the ASX Listing Rule 7.1 when calculating an entity's 15%
placement capacity.
D
is 10%
E
is the number of Equity Securities issued or agreed to be issued under ASX Listing Rule 7.1A.2
in the 12 months before the date of issue or agreement to issue that are not issued with the
approval of Shareholders under ASX Listing Rule 7.1 or 7.4.
Any equity securities issued under the 10% Placement Capacity must be in an existing quoted class of
the Company's equity securities. The Company presently has one class of quoted securities, being
Shares (ASX Code: WZR).
Page 12
If the Company issues any equity securities under the 10% Placement Capacity, the entity must,
pursuant to ASX Listing Rules 7.1A.4 and 3.10.5A:
(a)
give to ASX a list of the names of persons to whom the Company allotted equity securities and
the number of equity securities caused to be allotted to each (but this list is not required to be
released to the market); and
(b)
disclose to the market the details of the dilution to the existing holders of ordinary securities
caused by the issue; where the equity securities are issued for cash consideration, a statement
of the reasons why the eligible entity issued the equity securities as a placement rather than
as a pro rata issue; the details of any underwriting arrangement
Share your feedback
Discover